Market Overview
The global Apheresis Equipment Market was valued at approximately USD 4.02 billion in 2023 and is expected to grow at a CAGR of 10.9% from 2024 to 2030, reaching nearly USD 8.29 billion by 2030. Apheresis equipment plays an important role in modern blood-component collection and therapeutic procedures by separating specific components of blood, such as plasma, platelets, red blood cells, and white blood cells, while returning the remaining components to the patient or donor.
Get to Know More About This Market Study: https://www.maximizemarketresearch.com/request-sample/9977/
The increasing prevalence of cardiovascular diseases, hematological disorders, leukemia, sickle cell disease, and other blood-related conditions is generating sustained demand for apheresis procedures. In addition, the growing requirement for plasma and platelet collection, increasing numbers of blood donors, and improvements in transfusion medicine are supporting market expansion.
Technological advancements are also transforming apheresis systems. Modern equipment increasingly incorporates continuous-flow centrifugation, automated interface systems, customized anticoagulant infusion, screen navigation, graphical user interfaces (GUI), and automated process monitoring. These developments can improve operational efficiency, procedural consistency, and ease of use for healthcare professionals.
Government investments in healthcare infrastructure and research are another important factor supporting market development. Developed healthcare systems in North America and Europe continue to adopt sophisticated blood-processing technologies, while emerging economies in Asia-Pacific are increasing investments in hospitals, blood banks, and specialized treatment centers.
The COVID-19 pandemic temporarily disrupted blood collection activities, hospital procedures, supply chains, and elective treatments in several countries. However, the pandemic also highlighted the importance of resilient blood-collection infrastructure and advanced medical equipment. As healthcare systems returned to normal operations, demand for blood-component collection and therapeutic apheresis procedures recovered.
Market Drivers and Trends
Increasing Prevalence of Cardiovascular and Hematological Disorders
The growing incidence of cardiovascular diseases and hematological conditions is one of the major factors supporting the apheresis equipment market. Conditions such as leukemia, sickle cell disease, immune disorders, and other blood-related diseases can require therapeutic apheresis or transfusion-related procedures.
The increasing burden of chronic diseases is consequently encouraging hospitals and specialized treatment centers to invest in advanced blood-processing equipment. As the patient population requiring specialized blood-component treatment increases, demand for efficient apheresis systems is expected to rise.
Get to Know More About This Market Study: https://www.maximizemarketresearch.com/request-sample/9977/
Rising Demand for Blood Component Separation
Apheresis enables healthcare providers to collect or remove specific blood components rather than relying solely on conventional whole-blood collection. This makes the technology particularly valuable for platelet collection, plasma collection, leukocyte reduction, and therapeutic applications.
The increasing requirement for specific blood components in hospitals and transfusion centers is therefore creating opportunities for equipment manufacturers. Growing awareness regarding targeted blood-component collection is also supporting adoption.
Technological Advancements
Technological innovation is a major trend within the market. Equipment manufacturers are focusing on systems that provide greater automation, improved process control, and enhanced user interfaces.
Features such as continuous-flow centrifugation, automated interface management, customized anticoagulant delivery, touchscreen navigation, and GUI-based monitoring are improving the usability of apheresis systems. Automation can also help healthcare professionals manage complex procedures more efficiently.
Increasing Blood and Platelet Donations
The growing rate of platelet and plasma donation is another important market driver. Platelets have a relatively short storage life, creating a continuing requirement for efficient collection systems. Apheresis technology enables collection of larger quantities of specific blood components from individual donors, increasing its importance in blood banks and transfusion centers.
Healthcare Infrastructure Development
Governments and private healthcare organizations are increasing investments in healthcare infrastructure, particularly in emerging economies. The development of advanced hospitals, diagnostic centers, blood banks, and specialized oncology and hematology facilities is creating additional demand for apheresis equipment.
Primary Market Constraints
Despite strong growth prospects, the high cost associated with apheresis equipment remains a significant challenge. Advanced systems require substantial capital investment, while disposable components and maintenance can further increase the overall cost of procedures.
The cost barrier can be particularly significant for smaller hospitals and healthcare facilities in developing economies. Limited access to specialized healthcare infrastructure and trained professionals can also restrict adoption.
Another challenge is the requirement for skilled operators. Apheresis procedures involve sophisticated equipment and require healthcare professionals to understand blood-component separation, anticoagulation, patient monitoring, and equipment operation.
Supply-chain disruptions can also affect the availability of specialized disposable products and components. Healthcare providers therefore need reliable supply networks to maintain uninterrupted apheresis services.
Key Market Segments
By Process
The market is segmented into Plateletpheresis, Leukapheresis, Plasmapheresis, Erythrocytapheresis, and Others.
Plasmapheresis accounted for the largest market share, supported by increasing demand for plasma collection and therapeutic plasma exchange. Hematological and cardiovascular conditions requiring plasma-related interventions are contributing to segment growth.
Plasmapheresis is also increasingly important for the management of selected autoimmune and neurological disorders where removal or exchange of plasma can form part of a therapeutic strategy.
Photopheresis represents another important area of technological development and is expected to witness strong growth during the forecast period. The increasing use of photopheresis in conditions such as cutaneous T-cell lymphoma (CTCL), together with improvements in related technologies, is supporting its adoption.
Plateletpheresis is also expected to benefit from increasing platelet requirements and continued growth in platelet donation programs. Leukapheresis and erythrocytapheresis have specialized applications in hematology and transfusion medicine.
By Products
Based on products, the market is divided into Disposables and Devices.
The disposables segment represents an essential component of apheresis procedures because collection kits, tubing, filters, and other single-use components are required during treatment or collection. Increasing procedure volumes are consequently supporting recurring demand for disposables.
The devices segment includes the core apheresis systems used for blood separation and collection. Technological innovation and increasing automation are supporting the development of advanced devices.
By Application
The market is categorized into Blood Collection and Treatment.
Blood collection is supported by increasing demand for plasma and platelet collection and the growing need for specific blood components. Treatment applications are driven by increasing utilization of therapeutic apheresis for selected hematological, autoimmune, and other medical conditions.
By Technology
The market is segmented into Centrifugation and Membrane Filtration.
Centrifugation is widely used because it separates blood components according to their density. The technology is incorporated into numerous apheresis systems and supports the efficient collection of plasma, platelets, leukocytes, and other blood components.
Membrane filtration represents another important technology and is used in applications where blood components are separated through specialized filtration membranes.
Get to Know More About This Market Study: https://www.maximizemarketresearch.com/request-sample/9977/
Regional Performance
North America
North America held the largest share of the global Apheresis Equipment Market in 2023. Strong healthcare infrastructure, government support, high healthcare expenditure, advanced technology adoption, and significant research and development activity are key factors supporting regional dominance.
The United States represents the leading contributor to the North American market. Investment in healthcare technologies and the presence of advanced hospitals, blood centers, and specialized treatment facilities are creating a favorable environment for apheresis equipment adoption.
Asia-Pacific
Asia-Pacific is expected to register the highest growth rate during the forecast period. Increasing cardiovascular diseases, growing prevalence of blood cancers, improving healthcare infrastructure, and increasing adoption of advanced medical technologies are contributing to regional expansion.
Japan represents an important market in the region because of its aging population, increasing prevalence of cardiovascular disorders and blood-related diseases, and established healthcare infrastructure. China and India are also expected to provide significant opportunities because of healthcare modernization and increasing investment in medical infrastructure.
Europe
Europe represents another significant market, supported by developed healthcare systems, established blood donation networks, and increasing utilization of therapeutic apheresis. Germany, the United Kingdom, France, and Italy are among the important markets in the region.
Middle East & Africa and South America
Healthcare infrastructure development and improving access to specialized medical technologies are creating opportunities in the Middle East, Africa, and South America. Although adoption remains comparatively lower in several developing markets, investments in hospitals, blood banks, and specialized treatment centers are expected to support long-term growth.
Major Industry Players
The competitive landscape of the global Apheresis Equipment Market includes established medical-device and healthcare companies developing a range of blood-processing systems, consumables, and therapeutic technologies.
Key companies covered in the market include:
- Cerus Corporation
- Fresenius Medical Care
- Asahi Kasei Medical
- Fenwal
- Kawasumi Laboratories
- Haemonetics Corporation
- Terumo BCT
- Kaneka Corporation
- HemaCare Corporation
- Therakos
These companies focus on product development, technological improvements, strategic partnerships, geographic expansion, and enhancements to blood-component collection and therapeutic applications. Competition is increasingly centered on automation, procedure efficiency, user-friendly interfaces, safety, and the development of specialized apheresis solutions.
Frequently Asked Questions
1. What was the size of the Global Apheresis Equipment Market in 2023?
The Global Apheresis Equipment Market was valued at USD 4.02 billion in 2023.
2. What is the expected size of the Apheresis Equipment Market by 2030?
The market is expected to reach approximately USD 8.29 billion by 2030.
3. What is the growth rate of the Global Apheresis Equipment Market?
The Global Apheresis Equipment Market is projected to grow at a CAGR of 10.9% during the forecast period 2024–2030.
4. Which region held the largest share of the Apheresis Equipment Market?
North America held the largest market share in 2023, supported by advanced healthcare infrastructure, government support, high technology adoption, and significant healthcare investment.
5. Which region is expected to grow at the fastest rate?
Asia-Pacific is expected to register the highest growth rate during the forecast period, driven by increasing cardiovascular and blood-related diseases, healthcare infrastructure development, and adoption of advanced medical technologies.
Conclusion
The global Apheresis Equipment Market is positioned for substantial expansion, increasing from USD 4.02 billion in 2023 to nearly USD 8.29 billion by 2030, at a CAGR of 10.9%. Rising cardiovascular and hematological diseases, increasing demand for plasma and platelet collection, technological advancements, automation, and healthcare infrastructure investments are expected to remain key growth catalysts.
Connect With Us:
MAXIMIZE MARKET RESEARCH PVT. LTD.
2nd Floor, Navale IT park Phase 3,
Pune Banglore Highway, Narhe
Pune, Maharashtra 411041, India.
+91 9607365656
sales@maximizemarketresearch.com
About Maximize Market Research:
Maximize Market Research is one of the fastest-growing market research and business consulting firms serving clients globally. Our revenue impact and focused growth-driven research initiatives make us a proud partner of majority of the Fortune 500 companies. We have a diversified portfolio and serve a variety of industries such as IT & telecom, chemical, food & beverage, aerospace & defense, healthcare and others.
Comments (0)